Visit Janssen With Me
open
Visit your patient country site

Visit your patient country site

Visit your patient country site

Please select your country

You are now being directed to content for patients. After selecting your country, you will be re-directed to your patient country site.

References

[1]
Kostopoulos, Ioannis V., et al. "Minimal residual disease in multiple myeloma: current landscape and future applications with immunotherapeutic approaches." Frontiers in Oncology 10. 2020; 860.

Last updated October 21, 2022 — CP-348746

© Janssen Pharmaceutica NV 2024

This site is published by Janssen Pharmaceutica NV, which is solely responsible for its content. It is intended for visitors in Europe (excluding the UK), the Middle East and Africa.

Logo Janssen | Pharmaceutical Companies of Johnson & Johnson
Contact Us
Cookie Policy
Privacy Policy
Legal Notice
Editorial standards
Accessibility
Cookie Settings